Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A

301408 · SHE · Healthcare / Pharmaceutical Retailers

13.33CNY-0.52 (-3.75%)

Price History

Full chart

Market Stats

Previous Close13.85

Open13.81

Day Range13.30 – 13.86

52-Week Range12.10 – 29.58

Volume9.21M

Market Cap5.97B

P/E (TTM)26.66

Forward P/E0.00

EPS0.56

Dividend Yield0.67%

Beta0.74

50-Day Avg14.88

200-Day Avg17.80

About

Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, heat-clearing, respiratory system, and gynecology, as well as provides vitamins and minerals, and detoxifying products. In addition, it provides supplements, and nutrition and health products. Anhui Huaren Health Pharmaceutical Co., Ltd. was founded in 2001 and is based in Hefei, China.

Company Details

SectorHealthcare
IndustryPharmaceutical Retailers
CEOMr. Jiale He
Employees8.94K
HeadquartersHuaren Health Building, Hefei, China, 230051, China
Websitehttps://www.hrjkjt.com

Leadership

Mr. Jiale HeGM & Chairman of the Board · b. 1976
Ms. Mei LiCFO, Secretary & Accounting Supervisor · b. 1977
Mr. Jialun HeDeputy GM & Director · b. 1973
Mr. Jun YinDeputy GM & Director · b. 1980
Mr. Chunshui ZhaoDeputy GM & Employee Representative Director · b. 1981

Financials

Income Statement

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	2.34B	3.26B	3.80B	4.53B	5.49B
Growth (%)	-	+39.50%	+16.39%	+19.34%	+21.07%
Cost of Revenue	1.52B	2.20B	2.63B	3.05B	3.63B
Gross Profit	815.45M	1.06B	1.16B	1.48B	1.86B
Gross Margin	34.87%	32.58%	30.64%	32.62%	33.89%
Operating Expense	692.46M	817.37M	981.75M	1.22B	1.45B
Operating Income	122.99M	245.38M	181.68M	256.77M	412.96M
Operating Margin	5.26%	7.52%	4.78%	5.67%	7.53%
EBITDA	-	402.65M	389.30M	530.05M	661.21M
EBITDA Margin	-	12.34%	10.25%	11.70%	12.05%
Net Income	69.73M	160.78M	114.67M	137.70M	191.35M
Net Income Margin	2.98%	4.93%	3.02%	3.04%	3.49%
R&D	498.75K	4.17M	24.19M	29.39M	29.58M
R&D as % of Total Revenue	0.02%	0.13%	0.64%	0.65%	0.54%
Interest Expense	4.80M	23.38M	29.05M	32.15M	30.22M
Interest Expense % of Total Revenue	0.21%	0.72%	0.76%	0.71%	0.55%

Balance Sheet

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.97B	2.58B	4.61B	4.83B	5.49B
Total Liabilities	1.19B	1.63B	2.64B	2.77B	3.33B
Total Equity	784.80M	947.28M	1.94B	2.01B	2.10B
Cash	284.51M	482.10M	1.34B	999.69M	954.55M

Cash Flow

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	140.82M	173.84M	131.37M	571.76M	837.18M
Capital Expenditure	33.91M	104.77M	216.31M	160.89M	152.89M
Free Cash Flow	106.91M	69.07M	-84.93M	410.87M	684.29M
Dividends Paid	4.34M	4.13M	14.69M	55.98M	56.75M
FCF to OCF	75.92%	39.73%	-64.65%	71.86%	81.74%
Dividend Paid to FCF	4.06%	5.98%	-17.29%	13.63%	8.29%

Earnings

Report Date	Mar 31, 2023	Jun 30, 2023	Sep 30, 2023	Dec 31, 2023	Mar 31, 2024	Jun 30, 2024	Sep 30, 2024	Dec 31, 2024	Mar 31, 2025	Jun 30, 2025	Sep 30, 2025	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.07	0.07	0.07	0.07	0.12	0.06	0.09	0.07	0.15	0.11	0.13	0.09	0.20	0.14
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap5.97B

Enterprise Value6.55B

Trailing P/E26.66

Forward P/E0.00

Price / Sales1.03

Price / Book2.85

EPS0.56

Book Value5.30

Revenue (TTM)5.81B

Gross Profit (TTM)2.00B

EBITDA481.48M

Profit Margin3.85%

Operating Margin5.97%

Return on Equity11.67%

Return on Assets5.07%

Shares Outstanding400.01M

Shares Float142.08M

Beta0.74

Dividend Yield0.67%

Dividend Rate0.10

Payout Ratio17.89%

Dividends

20261×

0.10May 27, 2026

20251×

0.10Jun 25, 2025

20241×

0.10Jun 17, 2024